Background In patients with a minor ischaemic stroke or transient ischaemic attack (TIA),
separate trials have shown that dual antiplatelet therapy with clopidogrel plus aspirin …

Importance Dual antiplatelet therapy with clopidogrel and aspirin is effective for secondary
prevention after minor ischemic stroke or transient ischemic attack (TIA). Uncertainties …

Objective: To investigate the short-term time course risks and benefits of clopidogrel with
aspirin in minor ischemic stroke or TIA. Methods: Data were derived from the Clopidogrel in …

Background and Purpose—Disabling stroke is costly and considered by some patients a
fate worse than death. We aimed to determine whether clopidogrel reduces the rate and …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …

Background Clopidogrel was superior to aspirin in patients with previous manifestations of
atherothrombotic disease in the CAPRIE study and its benefit was amplified in some high …

Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …

Objective There is insufficient evidence on which to base a recommendation for optimal
antiplatelet therapy following a stroke while on aspirin. The objective was to compare …

BACKGROUND: Acute nondisabling cerebrovascular events are common and often portend
a disabling stroke. Aspirin is the only antiplatelet agent to have been studied in patients …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …